Health-sector reform in China and access to essential medicines

In 2009 the Chinese Government embarked on the most comprehensive health-sector reform since the economic reform of the 1970s, with a systematic plan to achieve universal health care by 2020. One of the key pillars of the reform is the establishment and implementation of a national essential medicines policy to ensure the safety, quality, supply, and affordability of medicines. In this issue of The Lancet Global Health, Yu Fang and colleagues1 report the effect of the reform on access to affordable essential medicines in Shaanxi Province in western China.

Abstract licence: CC BY-NC-ND

6 more references, whose wording the paper’s licence keeps private.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.